Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease (Q37350392)

19 August 2017

0 references

1 reference

title

Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease (English)

1 reference

19 August 2017

1 reference

1 reference

deep brain stimulation

1 reference

4

Pierre Pollak

1 reference

19 August 2017

Alim Louis Benabid

1

1 reference

PubMed ID

19081516

19 August 2017

Stephan Chabardes

series ordinal

2

1 reference

PubMed ID

19081516

19 August 2017

John Mitrofanis

series ordinal

3

1 reference

19 August 2017

1 January 2009

1 reference

19 August 2017

1 reference

19 August 2017

8

1 reference

19 August 2017

67-81

1 reference

19 August 2017

1

1 reference

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Alteration of hormone and neurotransmitter production in cultured cells by high and low frequency electrical stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Protection of nigral cell death by bilateral subthalamic nucleus stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

A randomized trial of deep-brain stimulation for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Predictors of effective bilateral subthalamic nucleus stimulation for PD

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian dysarthria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subthalamic nucleus stimulation in tremor dominant parkinsonian patients with previous thalamic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement: effects of reimplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Postoperative medical evaluation of 26 selected patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic parkinson's disease: one year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subthalamic stimulation in Parkinson disease: a multidisciplinary approach

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Deep brain stimulation of the subthalamic nucleus: clinical effectiveness and safety.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

The role of pulsatile versus continuous dopamine receptor stimulation for functional recovery in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Improvement of sleep architecture in PD with subthalamic nucleus stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Effect of subthalamic deep brain stimulation on the function of the urinary bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

The effect of deep brain stimulation on quality of life in movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Improvement in quality of life in patients with advanced Parkinson's disease following bilateral deep-brain stimulation in subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Staged unilateral versus bilateral subthalamic nucleus stimulator implantation in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Lifetime of Itrel II pulse generators for subthalamic nucleus stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Complications of deep brain stimulation surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Hemorrhagic complications of microelectrode-guided deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Management of hardware infections following deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery--experiences from a single centre

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson's disease. Review of 272 procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subthalamic nucleus deep brain stimulation in elderly patients--analysis of outcome and complications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Deep brain stimulator hardware-related infections: incidence and management in a large series

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Technical complication in deep brain stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Sudden failure of dual channel pulse generators

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Are complications less common in deep brain stimulation than in ablative procedures for movement disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Functional neurosurgery in the MRI environment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Do microelectrode techniques increase accuracy or decrease risks in pallidotomy and deep brain stimulation? A critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Cognitive outcomes after deep brain stimulation for Parkinson's disease: a review of initial studies and recommendations for future research

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Complications of deep brain stimulation surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

The behavioral complications of pallidal stimulation: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Preservation of cognitive function in dystonia treated by pallidal stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Deep brain stimulation: neuropsychological and neuropsychiatric issues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Deep-brain stimulation in Parkinson's disease: long-term efficacy and safety - What happened this year?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Reducing hardware-related complications of deep brain stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Hardware failure in parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Fracture of subthalamic nucleus deep brain stimulation hardware as a result of compulsive manipulation: case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Operative and hardware complications of deep brain stimulation for movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Deep brain stimulation for dystonia. Surgical technique.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Deep brain stimulation: postoperative issues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Pallidal deep-brain stimulation in primary generalized or segmental dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Two cases of ischemia associated with subthalamic nucleus stimulator implantation for advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Thirty days complication rate following surgery performed for deep-brain-stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Side-effects of subthalamic stimulation in Parkinson's disease: clinical evolution and predictive factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Behavioural disorders, Parkinson's disease and subthalamic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Postoperative management of subthalamic nucleus stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Suicide after successful deep brain stimulation for movement disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

1 reference

7 January 2021

Aggressive behavior induced by intraoperative stimulation in the triangle of Sano.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Mirthful laughter induced by subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Suicide after deep brain stimulation of the internal globus pallidus for dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Completed suicide in medical/surgical patients: who is at risk?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Suicide in recently released prisoners: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

PPN or PPD, what is the target for deep brain stimulation in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

The peripeduncular nucleus: a novel target for deep brain stimulation?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Stereotactic localization of the human pedunculopontine nucleus: atlas-based coordinates and validation of a magnetic resonance imaging protocol for direct localization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Extradural cortical stimulation for movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Results by motor cortex stimulation in treatment of focal dystonia, Parkinson's disease and post-ictal spasticity. The experience of the Italian Study Group of the Italian Neurosurgical Society.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subthalamic GAD gene therapy in a Parkinson's disease rat model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

From bench to bed: the potential of stem cells for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Subcutaneous apomorphine in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Advances in the delivery of treatments for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Therapeutic modulation of synaptic connectivity with desynchronizing brain stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Cost of illness and disease severity in a cohort of French patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

Ipsilateral sequential arm movements after unilateral subthalamic deep-brain stimulation in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970291-6

7 January 2021

10.1016/S1474-4422(08)70291-6

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

19081516